SCHEMBL6162649

SCHEMBL6162649

N#CCCn1nc(Cc2cccs2)c2c1CCC2=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.37
ALDH1A1 P00352 5/20 0.35
GAA P10253 2/20 0.35
MAPT P10636 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
LMNA P02545 2/20 0.35
USP2 O75604 4/20 0.33
MEN1 O00255 3/20 0.33
CYP1A2 P05177 3/20 0.33
CASP1 P29466 3/20 0.33
CASP7 P55210 3/20 0.33
KMT2A Q03164 3/20 0.33
HSD17B10 Q99714 3/20 0.33
MAPK1 P28482 3/20 0.33
CYP3A4 P08684 2/20 0.33
TSHR P16473 1/20 0.33
ALOX15 P16050 2/20 0.32
GLA P06280 1/20 0.32
HIF1A Q16665 1/20 0.32
CLK4 Q9HAZ1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6164529 0.85 HTT (0.42) PARP1ALDH1A1MAPTLMNAUSP2
SCHEMBL6165037 0.81 MAOB (0.42) ALDH1A1GAAMAPTMEN1CYP1A2
SCHEMBL6165490 0.81 LMNA (0.49) ALDH1A1GAAMAPTL3MBTL1LMNA
SCHEMBL6167036 0.71 RIPK3 (0.39) ALDH1A1MAPTKMT2ABRD4EP300
SCHEMBL6166254 0.70 ALDH1A1 (0.38) ALDH1A1GAAMAPTL3MBTL1LMNA
SCHEMBL6167954 0.69 HTT (0.32)
SCHEMBL6167558 0.68 BRD4 (0.31) BRD4EP300CREBBP
SCHEMBL6165983 0.68 ATM (0.44) ALDH1A1GAAMAPTCYP1A2KMT2A
SCHEMBL6164339 0.68 HTT (0.34) BRD4EP300CREBBP
SCHEMBL6164086 0.67 ALDH1A1 (0.36) ALDH1A1GAAMAPTMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed